🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single-center, Phase II trial designed to estimate i...
Status
Unknown
Location
Istituto Clinico Humanitas
Start Date
2020-01-30
Trial ID
NCT04435977
Treatments Being Tested
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
The main objective of this study is to observe and evaluate the safety and ...
Status
Recruiting
Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2025-05-30
Trial ID
NCT06980155
Treatments Being Tested
In registry studies of CAR-T products that have been marketed globally, pat...
Status
Unknown
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2023-06-10
Trial ID
NCT05871684
Treatments Being Tested
This is a single centre, proof-of-concept phase I trial of atezolizumab in ...
Status
Active Not Recruiting
Location
Royal Marsden Hospital NHS Foundation Trust
Start Date
2018-08-13
Trial ID
NCT03673787
Treatments Being Tested
Drugs called checkpoint inhibitors help the immune system fight cancer. Whe...
Status
Active Not Recruiting
Location
Hartford Healthcare
Start Date
2018-10-01
Trial ID
NCT03693014
Treatments Being Tested
Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment and...
Status
Recruiting
Location
Amsterdam UMC
Start Date
2023-01-25
Trial ID
NCT06519292
There is no standard treatment for chondrosarcoma. Some small sample of stu...
Status
Unknown
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2023-02-06
Trial ID
NCT05193188
Treatments Being Tested
BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Status
Active Not Recruiting
Location
University of Alabama
Start Date
2022-03-31
Trial ID
NCT05256290
Treatments Being Tested
Tyrosine kinase inhibitors (TKI) have revolutionized the management and pro...
Status
Active Not Recruiting
Location
Chu Angers
Start Date
2023-12-01
Trial ID
NCT05753384
Treatments Being Tested